Jim O’Neill’s nomination as second-in-command at the U.S. Department of Health and Human Services has sparked excitement among longevity enthusiasts. As a key ally of Robert F. Kennedy Jr., O’Neill is poised to influence health agencies responsible for funding biomedical research and regulating new drugs. Despite supporting established vaccine schedules and not fully aligning with Kennedy’s more controversial views, O’Neill could direct agencies toward debated policies. His strong connections within the well-funded longevity community have fostered optimism regarding his leadership and vision. Meanwhile, AI journalist Karen Hao’s new book, Empire of AI: Dreams and Nightmares in Sam Altman’s OpenAI, explores the implications of AI’s rapid growth. Hao will engage in a subscriber-exclusive Roundtable discussion on the impact of AI on the world, offering attendees a chance to win a free copy of her book. Join the conversation and gain insights into the evolving tech landscape.
